NASDAQ:MMED

MiniMed Group (MMED) Stock Price, News & Analysis

MiniMed Group logo
$17.45 -0.33 (-1.83%)
As of 01:42 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About MiniMed Group Stock (NASDAQ:MMED)

Advanced

Key Stats

Today's Range
$17.36
▼
$18.24
50-Day Range
$16.71
▼
$22.76
52-Week Range
$10.65
▼
$24.43
Volume
1.64 million shs
Average Volume
3.64 million shs
Market Capitalization
$4.91 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$24.13
Consensus Rating
Moderate Buy

Company Overview

MiniMed Group focuses on diabetes technology, developing products and services to help people manage insulin-dependent diabetes. Its offerings include insulin pumps, continuous glucose monitoring systems, infusion sets and software for tracking glucose and coordinating insulin delivery.

The business is known for automated insulin-delivery systems that use glucose readings to help adjust insulin delivery, including products in the MiniMed 780G system line. Its technologies are intended for use by people with diabetes and the clinicians who support their care.

MiniMed’s operations trace to Medtronic’s diabetes business, which developed and marketed diabetes-management products internationally. MiniMed products and services have been offered in multiple markets, though availability varies by location.

AI Generated. May Contain Errors.

MiniMed Group Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
68th Percentile Overall Score

MMED MarketRank™: 
3.40281465746 of 5 stars

MiniMed Group scored higher than 68% of companies evaluated by MarketBeat, and ranked 231st out of 859 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    MiniMed Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.68, and is based on no strong buy ratings, 14 buy ratings, 4 hold ratings, and 1 sell rating.

  • Upside Potential

    MiniMed Group has a consensus price target of $24.13, representing about 37.4% upside from its current price of $17.56.

  • Amount of Analyst Coverage

    MiniMed Group has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about MiniMed Group's stock forecast and price target.
  • Earnings Growth

    Earnings for MiniMed Group are expected to decrease by -13.89% in the coming year, from $0.72 to $0.62 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of MiniMed Group is -25.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of MiniMed Group is -25.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    MiniMed Group has a P/B Ratio of 1.37. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    3.49% of the float of MiniMed Group has been sold short.
  • Short Interest Ratio / Days to Cover

    MiniMed Group has a short interest ratio ("days to cover") of 0.96, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in MiniMed Group has recently decreased by 52.80%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    MiniMed Group does not currently pay a dividend.

  • Dividend Growth

    MiniMed Group does not have a long track record of dividend growth.

  • News Sentiment

    MiniMed Group has a news sentiment score of 0.74. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 9 news articles for MiniMed Group this week, compared to 3 articles on an average week.
  • MarketBeat Follows

    Only 3 people have added MiniMed Group to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, MiniMed Group insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    0.02% of the stock of MiniMed Group is held by insiders.

  • Percentage Held by Institutions

    MiniMed Group has minimal institutional ownership at this time.

  • Read more about MiniMed Group's insider trading history.
Receive MMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MiniMed Group and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MMED Stock News Headlines

MiniMed Group: An Improving Proposition
Your free book is about to disappear
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel
MiniMed Group Inc (MMED) - What Are Analysts Saying About This Stock?
MiniMed Group, Inc. (MMED)
MiniMed to Participate in Upcoming Investor Conferences
See More Headlines

MMED Stock Analysis - Frequently Asked Questions

MiniMed Group's stock was trading at $18.00 on March 9, 2026. Since then, MMED shares have decreased by 2.5% and is now trading at $17.5550.

MiniMed Group Inc (NASDAQ:MMED) released its earnings results on Wednesday, June, 3rd. The company reported ($0.68) EPS for the quarter, missing analysts' consensus estimates of ($0.22) by $0.46. The company's quarterly revenue was up 15.6% compared to the same quarter last year.
Read the conference call transcript
.

MiniMed Group (MMED) raised $742 million in an initial public offering (IPO) on Thursday, March 5th 2026. The company issued 28,000,000 shares at a price of $25.00-$28.00 per share.

MiniMed Group's top institutional shareholders include Healthcare of Ontario Pension Plan Trust Fund (0.61%), Boston Partners (0.32%), First Trust Advisors LP (0.29%) and State Street Corp (0.25%).

Shares of MMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
11/18/2026
9th Annual Evercore ISI HealthCONx Conference
12/01/2026
Citi Annual Global Healthcare Conference 2026
12/02/2026
38th Annual Healthcare Conference
12/03/2026
Fiscal Year End
4/30/2027

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:MMED
CIK
2062583
Fax
N/A
Employees
2,800
Year Founded
N/A

Price Target and Rating

High Price Target
$30.00
Low Price Target
$16.00
Potential Upside/Downside
+38.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.68
Research Coverage
19 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
28.15
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.81
Quick Ratio
1.36

Sales & Book Value

Annual Sales
$3.10 billion
Price / Sales
1.58
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$12.86 per share
Price / Book
1.36

Miscellaneous

Outstanding Shares
281,350,000
Free Float
281,294,000
Market Cap
$4.91 billion
Optionable
Optionable
Beta
N/A
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

This page (NASDAQ:MMED) was last updated on 11/18/2026 by MarketBeat.com Staff.
From Our Partners